Compared with the general population of patients with type 2 diabetes, the study population appears to have less advanced disease due to the exclusion of people with diabetes taking insulin and patients with diagnosed micro- and macro-vascular diabetes complications. This evidence concerns the gene INS and diabetes mellitus.